Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.

Propensity for developing coronary heart disease (CHD) is linked with Framingham-defined cardiovascular risk factors and elevated inflammatory biomarkers. Cardiovascular risk and inflammatory biomarkers were evaluated in ARIES, a Phase IIIb/IV clinical trial in which 515 antiretroviral-naive HIV-infected subjects initially received abacavir/lamivudine + atazanavir/ritonavir for 36 weeks. Subjects who were virologically suppressed by week 30 were randomized 1:1 at week 36 to either maintain or discontinue ritonavir for an additional 108 weeks. Framingham 10-year CHD risk scores (FRS) and risk category o

Quantum phase transition in the Frenkel-Kontorova chain: from pinned instanton glass to sliding phonon gas

We study analytically and numerically the one-dimensional quantum Frenkel-Kontorova chain in the regime when the classical model is located in the pinned phase characterized by the gaped phonon excitations and devil's staircase. By extensive quantum Monte Carlo simulations we show that for the effective Planck constant $\hbar$ smaller than the critical value $\hbar_c$ the quantum chain is in the pinned instanton glass phase. In this phase the elementary excitations have two branches: phonons, separated from zero energy by a finite gap, and instantons which have an exponentially small excitation energy. At $\hbar=\hbar_c$ the quantum phase transition takes place and for $\hbar>\hbar_c$ the pinned instanton glass is transformed into the sliding phonon gas with gapless phonon excitations. This transition is accompanied by the divergence of the spatial correlation length and appearence of sliding modes at $\hbar>\hbar_c$.Comment: revtex 16 pages, 18 figure

The absolute infrared magnitudes of type Ia supernovae

The absolute luminosities and homogeneity of early-time infrared (IR) light curves of type Ia supernovae are examined. Eight supernovae are considered. These are selected to have accurately known epochs of maximum blue light as well as having reliable distance estimates and/or good light curve coverage. Two approaches to extinction correction are considered. Owing to the low extinction in the IR, the differences in the corrections via the two methods are small. Absolute magnitude light curves in the J, H and K-bands are derived. Six of the events, including five established ``Branch-normal'' supernovae show similar coeval magnitudes. Two of these, SNe 1989B and 1998bu, were observed near maximum infrared light. This occurs about 5 days {\it before} maximum blue light. Absolute peak magnitudes of about -19.0, -18.7 and -18.8 in J, H & K respectively were obtained. The two spectroscopically peculiar supernovae in the sample, SNe 1986G and 1991T, also show atypical IR behaviour. The light curves of the six similar supernovae can be represented fairly consistently with a single light curve in each of the three bands. In all three IR bands the dispersion in absolute magnitude is about 0.15 mag, and this can be accounted for within the uncertainties of the individual light curves. No significant variation of absolute IR magnitude with B-band light curve decline rate, Delta m_{15}(B), is seen over the range 0.87<Delta m_{15}(B)<1.31. However, the data are insufficient to allow us to decide whether or not the decline rate relation is weaker in the IR than in the optical region. IR light curves of type Ia supernovae should eventually provide cosmological distance estimates which are of equal or even superior quality to those obtained in optical studies.Comment: 19 pages, 9 figures, MNRAS in press (includes Referee's changes

Unemployment Insurance and Low-Educated Single Working Mothers Before and After Welfare Reform

Using the Survey of Income and Program Participation (SIPP), a nationally representative, longitudinal survey, this study examines changing levels of Unemployment Insurance (UI) eligibility and benefit receipt among working low-educated single mothers, 1990–2005. It also examines changing participation in cash welfare and the Food Stamp Program (FSP). Relative to single childless women, there has been no increase in UI benefit receipt among single mothers entering a spell of unemployment in the postreform period, even though single mothers have increased their relative rates of UI eligibility. Because of declining cash assistance receipt, UI became a more common income support than cash assistance for this population during the period 2001–2005. Furthermore, the probability of accessing FSP for low-educated single mothers entering a spell of unemployment increased in the years 2001–2005. As a result, the proportion of this population accessing benefits from one or more of these programs remained virtually unchanged across the study period

Supernova Bounds on Resonant Active-Sterile Neutrino Conversions

We discuss the effects of resonant $\nu_e \to \nu_s$ and $\bar{\nu}_e \to \bar{\nu}_s$ ($\nu_s$ is a sterile neutrino) conversions in the dense medium of a supernova. In particular, we assume the sterile neutrino $\nu_s$ to be in the hot dark matter few eV mass range. The implications of such a scenario for the supernova shock re-heating, the detected $\bar\nu_e$ signal from SN1987A and for the r-process nucleosynthesis hypothesis are analysed in some detail. The resulting constraints on mixing and mass difference for the $\nu_e-\nu_s$ system are derived. There is also an allowed region in the neutrino parameter space for which the r-process nucleosynthesis can be enhanced.Comment: Latex file, 27 pages including 10 ps figures, uses psfig.sty. Few references added, some change in the Acknowledgements and some minor corrections in the tex

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.

A retrospective analysis of the randomized controlled DART (Development of AntiRetroviral Therapy in Africa; ISRCTN13968779) trial in HIV-1-positive adults initiating antiretroviral therapy with co-formulated zidovudine/lamivudine plus either tenofovir, abacavir, or nevirapine was conducted to evaluate the safety of initiating standard lamivudine dosing in patients with impaired creatinine clearance (CLcr). Safety data collected through 96 weeks were analyzed after stratification by baseline CLcr (estimated using Cockcroft-Gault) of 30-49 mL/min (n = 168) versus ≥50 mL/min (n = 3,132) and treatment regimen. The Grade 3-4 adverse events (AEs) and serious AEs (for hematological, hepatic and gastrointestinal events), maximal toxicities for liver enzymes, serum creatinine and bilirubin and maximum treatment-emergent hematology toxicities were comparable for groups with baseline CLcr 30-49 versus CLcr≥50 mL/min. No new risks or trends were identified from this dataset. Substantial and similar increases in the mean creatinine clearance (>25 mL/min) were observed from baseline though Week 96 among participants who entered the trial with CLcr 30-49 mL/min, while no increase or smaller median changes in creatinine clearance ( 150 cells/ mm3) in mean CD4+ cells counts from baseline to Week 96 were also observed for participants who entered the trial with CLcr 30-49 mL/min and those with baseline CLcr ≥50 mL/min. Though these results are descriptive, they suggest that HIV-positive patients with CLcr of 30-49 mL/min would have similar AE risks in comparison to patients with CLcr ≥50 mL/min when initiating antiretroviral therapy delivering doses of 300 mg of lamivudine daily through 96 weeks of treatment. Overall improvements in CLcr were observed for patients with baseline CLcr 30-49 mL/min

Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension

The pattern of the left ventricle (LV) has important significance in adults with hypertension. The aim of the present study was to analyze changes and determinants of LV geometry after 1 year of antihypertensive treatment in children with primary hypertension (PH) in relation to metabolic abnormalities and anthropometrical parameters. In 86 children (14.1 ± 2.4 years) with newly diagnosed PH, LV geometry and biochemical parameters before and after 12 months of standard antihypertensive therapy were assessed. At baseline, normal LV geometry (NG) was found in 42 (48.9%), concentric remodeling (CR) in 4 (4.6%), concentric hypertrophy (CH) in 8 (9.3%), and eccentric hypertrophy (EH) in 32 (37.2%) patients. The prevalence of NG in patients with severe hypertension was significantly lower than in patients with ambulatory hypertension. There were no differences in dipping status in relation to LV geometry. Patients with CH and EH were more viscerally obese than patients with NG. Patients with CH had higher diastolic blood pressure in comparison with EH patients (p < 0.05). The main predictor of relative wall thickness (RWT) was the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio (R2 = 0.319, β = 0.246, p = 0.004). Patients received 12 months of antihypertensive treatment, either lifestyle modification only (n = 37) or lifestyle modification plus antihypertensive medications (n = 49) if severe ambulatory hypertension or target organ damage were present. After 12 months of treatment the prevalence of EH (37.2% vs 18.6%, p = 0.003) decreased but prevalence of CH did not change. Patients in whom RWT decreased also decreased waist circumference and TG/HDL; the main predictor of RWT decrease was a decrease of the TG/HDL ratio (β = 0.496, R2 = 0.329, p = 0.002). In adolescents with PH, LV geometry is related to central obesity and insulin resistance. Decrease of abdominal obesity and insulin resistance are the most important predictors of normalization of LV geometry, however CH has lower potential to normalize LV geometry